Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

New England Journal of Medicine

Volumn 359, Issue 8, 2008, Pages 810-820

  Lovell, Daniel J ^a   Ruperto, Nicolino ^b   Goodman, Steven ^c   Reiff, Andreas ^d   Jung, Lawrence ^e   Jarosova, Katerina ^f   Nemcova, Dana ^g   Mouy, Richard ^h   Sandborg, Christy ⁱ   Bohnsack, John ^j   Elewaut, Dirk ^k   Foeldvari, Ivan ^l   Gerloni, Valeria ^m   Rovensky, Jozef ⁿ   Minden, Kirsten ^o   Vehe, Richard K ^p   Weiner, L Wagner ^q   Horneff, Gerd ^r   Huppertz, Hans Iko ^s   Olson, Nancy Y ^t   Medich, John R ^u   Carcereri De Prati, Roberto ^v   McIlraith, Melissa J ^v   Giannini, Edward H ^a   Martini, Alberto ^b   more..

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b G GASLINI INSTITUTE   (Italy)

^c Arthritis Associates of South Florida   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^f INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^g CHARLES UNIVERSITY   (Czech Republic)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^j UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^k GHENT UNIVERSITY HOSPITAL   (Belgium)

^l Hamburger Zentrum fur Kinder und Jugendrheumatologie   (Germany)

^m ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

ⁿ NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^o CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^p UNIVERSITY OF MINNESOTA   (United States)

^q UNIVERSITY OF CHICAGO   (United States)

^r Zentrum für Allgemeine Pädiatrie und Neonatologie   (Germany)

^s KLINIKUM BREMEN MITTE   (Germany)

^t UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^u ABBOTT LABORATORIES   (United States)

^v ABBOTT GMBH AND CO KG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISONE;

ABDOMINAL PAIN; ADOLESCENT; ARTHRALGIA; ARTICLE; BRONCHOPNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONTUSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOOD AND DRUG ADMINISTRATION; GASTROENTERITIS; HEMATOCHEZIA; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HYDROCEPHALUS; INJECTION SITE REACTION; JUVENILE RHEUMATOID ARTHRITIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUTROPENIA; PHARYNGITIS; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VOMITING;

EID: 49949115223     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0706290     Document Type: Article

References (14)

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
2. Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis: results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N Engl J Med 1992;326:1043-9.
3. Ruperto N, Murray KJ, Gerloni V, et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 2004;50:2191-201.
4. Genovese MC, Bathon JM, Fleischmann RM, et al. Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis. J Rheumatol 2005;32:1232-42.
5. Keystone EC, Kavanaugh AF, Sharp JT, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 2004;50:1400-11.
6. Maini RN, Breedveld FC, Kalden JR, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 2004;50:1051-65.
7. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000;342:763-9.
8. Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37.
9. van de Putte LBA, Atkins C, Malaise M, et al. Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis 2004;63:508-16.
10. Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human antitumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003;48:35-45. [Erratum, Arthritis Rheum 2003;48:855.]
11. Weinblatt ME, Keystone EC, Furst DE, Kavanaugh AF, Chartash EK, Segurado OG. Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study. Ann Rheum Dis 2006;65:753-9.
12. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-91.
13. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DR, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
14. Humira (adalimumab). North Chicago, IL: Abbott Laboratories, 2008 (package insert).